SlideShare a Scribd company logo
1 of 24
Investigation of the Effects
of Innate Immune
Activation on Cell Death on
a Neuronal Cell Line
Kelly Moore
4th Year Project
Supervisor: Dr. Declan McKernan
Lab Mentor: Laura Olsen
Innate Immune System
• Activated immediately following infection or injury
• Body’s first line of defence
• Invading pathogen is detected by Dendritic cells and
macrophages
• Network of pattern recognition receptors (PRRs) e.g. Toll-
like receptors
• Recognise pathogen associated molecular patterns (PAMPs)
• Production of pro-inflammatory cytokines & chemokines
• Causing either inflammation or phagocytosis
Toll-Like Receptors
• Transmembrane signalling proteins expressed on immune
cells
• 10 TLRs in humans
• Located on either plasma membrane or internal membrane
• Expressed in tissues involved in immune function, such as
spleen leukocytes, lung , GIT and Brain.
• Activation of TLRs leads to production of Cytokines,
chemokines or IFNs
• Causes immune response
Toll-like Receptor 3
• Expressed on endosomes
• Recognize dsRNA produced during
viral replication
• Mediates signals via TRIF
• Activates the transcription factors
IRF-3, NF-κB,AP-1
• In turn, induces the production of
type 1 interferons
• Anti-viral host defence
TLR3 in the brain
 TLR3 causes inflammatory responses and breaks down
the BBB
 The TLR3 triggers IFN expression and restricts viral
replication and spread of virus beyond the site of
entry
 TLR3 can cause the formation of Lewy bodies a
hallmark of Parkinson’s disease
Parkinson’s Disease
 Neuroinflammation triggered by pathogens can be associated
with PD
 Progressive neurodegenerative disorder
 Results from a pathophysiologic loss or degeneration of
dopaminergic neurons in the substantia nigra and the presence of
α-synuclein aggregates , Lewy Bodies
 Models of PD – Rotenone, 6-OHDA or MPTP
Cell death
 Can be attributed to both the
Immune activation of TLR3 and PD
 Cells receive apoptotic stimuli
 Mitochondria releases cytochrome c
 Recruits caspase-9
 Results in a caspase cascade
pyr
Aim
To determine if viral infection in a cell culture
system exacerbates the cell death induced by
Parkinson’s disease.
Hypothesis
Viral infection mimicked by Poly (I:C) in SH-SY5Y
neuronal cells will exacerbate the cell death
induced by a neurotoxin MPTP.
SHSY-5Y Cells
• Neuroblastoma cells
• Bone marrow from 4
year old female
• Characteristics of
dopaminergic neurons
Experimental Design
Group 1: Control
• No drug
treatment
Group 2: Poly IC
• Poly IC
• Medium
Group 3: MPP+
• Medium
• MPP+
Group 4:
Experimental
• Poly I:C
• MPP+
Treatments
MPP+: neurotoxin, mimics PD,
• 20ug/ml for 24 hours
Poly I:C: synthetic analogue of dsRNA
• 20ug/ml for 24 hours
Methods
• MTT assay
• Western blotting
MTT Assay
Western Blotting
Gel electrophoresis Transfer Antibody
Results
Cleaved PARP Western Blot
cPARP 89 kDa
Β-Actin 42 kDA
Figure 1: Western blot with cPARP compared to β-
Actin, showing all treatment groups
89 kDa
87 kDa
Figure 2: Zoomed image of the
cPARP band.
Showing the presence of two bands
of different molecular weight.
Figure 2: Ratio of 87kDa cPARP over β-actin
for each treatment group. n=3
Mean +/- SEM, Significant if P<0.05.
Figure 3: Ratio of 89 kDa cPARP over β-actin
for each treatment group. n=3
Mean +/- SEM, Significant if P<0.05.
Figure 4: Bar chart representing
the % of viable cells for each
treatment group. n =6.
Presented as Mean +/- SEM,
*** p< 0.001, significant difference
compared to both control and Poly
(I:C) groups.
Discussion
 Caspase 3 cleaves many different substrates including PARP.
 cPARP can be used as a marker of cleaved Caspase 3 activity, indirectly
measuring apoptosis.
 cCaspase-3 can stimulate apoptosis.
Discussion
 From the western blot analysis we can see a trend, showing an increase in
cPARP in each treatment group, especially in the Poly I:C group. Indicates
there is caspase 3 activity.
 We see a significant decrease in the amount of viable cells, when treated
with MPP+ and the combination of Poly (I:C) and MPP+.
 However, MTT assay can only tell us that cell death occurred, and can’t
specify what type of cell death.
 MPP+ could be causing other forms of cell death apart form apoptosis, this
is why the western blot doesn’t correlate with the MTT assay, as cCaspase-
3 can only indicate apoptosis.
Conclusion
 The neurotoxin MPP+ mimicking PD, significantly decreases cell
viability, however we do not know by what means.
 Poly I:C, the viral mimetic causes an increase cPARP expression
indicating cCaspase-3 activity, indicting apoptosis may be
occurring.
Further Studies
 Further studies should be carried out to determine what types of cell death
occurs. Perhaps doing more western blots probing for proteins involved in other
forms of cell death, such as necrosis or pyroptosis.
 Different time points should be carried out as the dose of Poly I:C used is quiet
small and doesn’t cause cell death immediately, it usually causes inflammation
first.
 Future experiments, should increase the n number, to get a better picture of the
effects of both drugs in combination.
Acknowledgements
 I would like to thank Dr. Declan McKernan and
Ms Laura Olsen.
 I would also like to thank all the staff in the
department of Pharmacology, especially the
staff in the CNS lab.
 Finally I would like to thank the girls in my
group for all their help and support.
Thank You!

More Related Content

What's hot

Apoptosis in Bacteria - Programmed cell death in prokaryotic cells
Apoptosis in Bacteria - Programmed cell death in prokaryotic cellsApoptosis in Bacteria - Programmed cell death in prokaryotic cells
Apoptosis in Bacteria - Programmed cell death in prokaryotic cells
Rivkah Epstein
 
Regulation of embryonic stem cell pluripotency by heat
Regulation of embryonic stem cell pluripotency by heatRegulation of embryonic stem cell pluripotency by heat
Regulation of embryonic stem cell pluripotency by heat
Mahmoud El Beblawy
 

What's hot (20)

Anticancer activity of withania somnifera on h ep 2 cell
Anticancer activity of withania somnifera on h ep 2 cellAnticancer activity of withania somnifera on h ep 2 cell
Anticancer activity of withania somnifera on h ep 2 cell
 
Stratified Medicine in Cancer: The Role of Histopathologist
Stratified Medicine in Cancer: The Role of HistopathologistStratified Medicine in Cancer: The Role of Histopathologist
Stratified Medicine in Cancer: The Role of Histopathologist
 
Apopotosis why and how ?
Apopotosis why and how ?Apopotosis why and how ?
Apopotosis why and how ?
 
Seminario biomol
Seminario biomolSeminario biomol
Seminario biomol
 
Cell death
Cell deathCell death
Cell death
 
Seminario
SeminarioSeminario
Seminario
 
Apoptosis
ApoptosisApoptosis
Apoptosis
 
Health Canada Genetic Tox Lecture Part 1
Health Canada Genetic Tox Lecture Part 1Health Canada Genetic Tox Lecture Part 1
Health Canada Genetic Tox Lecture Part 1
 
Japanese encephalitis virus
Japanese encephalitis virusJapanese encephalitis virus
Japanese encephalitis virus
 
Apoptosis
ApoptosisApoptosis
Apoptosis
 
Apoptosis in Bacteria - Programmed cell death in prokaryotic cells
Apoptosis in Bacteria - Programmed cell death in prokaryotic cellsApoptosis in Bacteria - Programmed cell death in prokaryotic cells
Apoptosis in Bacteria - Programmed cell death in prokaryotic cells
 
BOC 134 lecture - 7 Cell Death
BOC 134 lecture - 7 Cell DeathBOC 134 lecture - 7 Cell Death
BOC 134 lecture - 7 Cell Death
 
targeting
targetingtargeting
targeting
 
Inhibition of the mtorc pathway in the antiphospholipid
Inhibition of the mtorc pathway in the antiphospholipidInhibition of the mtorc pathway in the antiphospholipid
Inhibition of the mtorc pathway in the antiphospholipid
 
Apoptosis basics + microphotographs
Apoptosis basics + microphotographsApoptosis basics + microphotographs
Apoptosis basics + microphotographs
 
Regulation of embryonic stem cell pluripotency by heat
Regulation of embryonic stem cell pluripotency by heatRegulation of embryonic stem cell pluripotency by heat
Regulation of embryonic stem cell pluripotency by heat
 
Apoptosis
ApoptosisApoptosis
Apoptosis
 
Apoptosis
ApoptosisApoptosis
Apoptosis
 
Health Canada Genetic Tox Lecture Part 2
Health Canada Genetic Tox Lecture Part 2Health Canada Genetic Tox Lecture Part 2
Health Canada Genetic Tox Lecture Part 2
 
3targeting
3targeting3targeting
3targeting
 

Similar to Investigation of the Effects of Innate Immune Activation on Cell Death on a Neuronal Cell Line

Pharm immuno3 &4 q innate immunity & complement
Pharm immuno3 &4 q innate immunity & complementPharm immuno3 &4 q innate immunity & complement
Pharm immuno3 &4 q innate immunity & complement
mmoney1
 

Similar to Investigation of the Effects of Innate Immune Activation on Cell Death on a Neuronal Cell Line (20)

Apoptosis
ApoptosisApoptosis
Apoptosis
 
Programmed Cell death or Apoptosis
Programmed Cell death or ApoptosisProgrammed Cell death or Apoptosis
Programmed Cell death or Apoptosis
 
Apoptosis
ApoptosisApoptosis
Apoptosis
 
Immunocompetence tests
Immunocompetence testsImmunocompetence tests
Immunocompetence tests
 
Pharm immuno3 &4 q innate immunity & complement
Pharm immuno3 &4 q innate immunity & complementPharm immuno3 &4 q innate immunity & complement
Pharm immuno3 &4 q innate immunity & complement
 
Cell death,regulators, apoptosis,necrosis,autophagy
Cell death,regulators, apoptosis,necrosis,autophagyCell death,regulators, apoptosis,necrosis,autophagy
Cell death,regulators, apoptosis,necrosis,autophagy
 
430_2008_Article_81
430_2008_Article_81430_2008_Article_81
430_2008_Article_81
 
Apoptosis
ApoptosisApoptosis
Apoptosis
 
Apoptosis
ApoptosisApoptosis
Apoptosis
 
Genetic Engineering
Genetic EngineeringGenetic Engineering
Genetic Engineering
 
Apoptosis
ApoptosisApoptosis
Apoptosis
 
Apoptosis.pdf
Apoptosis.pdfApoptosis.pdf
Apoptosis.pdf
 
Apoptosis
ApoptosisApoptosis
Apoptosis
 
Parasite immunology
Parasite immunologyParasite immunology
Parasite immunology
 
Apoptosis definition, mechanism , Apoptosis vs necrosis, Assays of apoptosis,...
Apoptosis definition, mechanism , Apoptosis vs necrosis, Assays of apoptosis,...Apoptosis definition, mechanism , Apoptosis vs necrosis, Assays of apoptosis,...
Apoptosis definition, mechanism , Apoptosis vs necrosis, Assays of apoptosis,...
 
Complement presentation
Complement presentationComplement presentation
Complement presentation
 
Apoptosis roohit
Apoptosis roohitApoptosis roohit
Apoptosis roohit
 
Slide share
Slide shareSlide share
Slide share
 
International Journal of Pharmaceutical Science Invention (IJPSI)
International Journal of Pharmaceutical Science Invention (IJPSI)International Journal of Pharmaceutical Science Invention (IJPSI)
International Journal of Pharmaceutical Science Invention (IJPSI)
 
Cell cycle and apoptosis
Cell cycle and apoptosisCell cycle and apoptosis
Cell cycle and apoptosis
 

Investigation of the Effects of Innate Immune Activation on Cell Death on a Neuronal Cell Line

  • 1. Investigation of the Effects of Innate Immune Activation on Cell Death on a Neuronal Cell Line Kelly Moore 4th Year Project Supervisor: Dr. Declan McKernan Lab Mentor: Laura Olsen
  • 2. Innate Immune System • Activated immediately following infection or injury • Body’s first line of defence • Invading pathogen is detected by Dendritic cells and macrophages • Network of pattern recognition receptors (PRRs) e.g. Toll- like receptors • Recognise pathogen associated molecular patterns (PAMPs) • Production of pro-inflammatory cytokines & chemokines • Causing either inflammation or phagocytosis
  • 3. Toll-Like Receptors • Transmembrane signalling proteins expressed on immune cells • 10 TLRs in humans • Located on either plasma membrane or internal membrane • Expressed in tissues involved in immune function, such as spleen leukocytes, lung , GIT and Brain. • Activation of TLRs leads to production of Cytokines, chemokines or IFNs • Causes immune response
  • 4. Toll-like Receptor 3 • Expressed on endosomes • Recognize dsRNA produced during viral replication • Mediates signals via TRIF • Activates the transcription factors IRF-3, NF-κB,AP-1 • In turn, induces the production of type 1 interferons • Anti-viral host defence
  • 5. TLR3 in the brain  TLR3 causes inflammatory responses and breaks down the BBB  The TLR3 triggers IFN expression and restricts viral replication and spread of virus beyond the site of entry  TLR3 can cause the formation of Lewy bodies a hallmark of Parkinson’s disease
  • 6. Parkinson’s Disease  Neuroinflammation triggered by pathogens can be associated with PD  Progressive neurodegenerative disorder  Results from a pathophysiologic loss or degeneration of dopaminergic neurons in the substantia nigra and the presence of α-synuclein aggregates , Lewy Bodies  Models of PD – Rotenone, 6-OHDA or MPTP
  • 7. Cell death  Can be attributed to both the Immune activation of TLR3 and PD  Cells receive apoptotic stimuli  Mitochondria releases cytochrome c  Recruits caspase-9  Results in a caspase cascade pyr
  • 8.
  • 9. Aim To determine if viral infection in a cell culture system exacerbates the cell death induced by Parkinson’s disease. Hypothesis Viral infection mimicked by Poly (I:C) in SH-SY5Y neuronal cells will exacerbate the cell death induced by a neurotoxin MPTP.
  • 10. SHSY-5Y Cells • Neuroblastoma cells • Bone marrow from 4 year old female • Characteristics of dopaminergic neurons Experimental Design
  • 11. Group 1: Control • No drug treatment Group 2: Poly IC • Poly IC • Medium Group 3: MPP+ • Medium • MPP+ Group 4: Experimental • Poly I:C • MPP+ Treatments MPP+: neurotoxin, mimics PD, • 20ug/ml for 24 hours Poly I:C: synthetic analogue of dsRNA • 20ug/ml for 24 hours
  • 12. Methods • MTT assay • Western blotting
  • 16. Cleaved PARP Western Blot cPARP 89 kDa Β-Actin 42 kDA Figure 1: Western blot with cPARP compared to β- Actin, showing all treatment groups 89 kDa 87 kDa Figure 2: Zoomed image of the cPARP band. Showing the presence of two bands of different molecular weight.
  • 17. Figure 2: Ratio of 87kDa cPARP over β-actin for each treatment group. n=3 Mean +/- SEM, Significant if P<0.05. Figure 3: Ratio of 89 kDa cPARP over β-actin for each treatment group. n=3 Mean +/- SEM, Significant if P<0.05.
  • 18. Figure 4: Bar chart representing the % of viable cells for each treatment group. n =6. Presented as Mean +/- SEM, *** p< 0.001, significant difference compared to both control and Poly (I:C) groups.
  • 19. Discussion  Caspase 3 cleaves many different substrates including PARP.  cPARP can be used as a marker of cleaved Caspase 3 activity, indirectly measuring apoptosis.  cCaspase-3 can stimulate apoptosis.
  • 20. Discussion  From the western blot analysis we can see a trend, showing an increase in cPARP in each treatment group, especially in the Poly I:C group. Indicates there is caspase 3 activity.  We see a significant decrease in the amount of viable cells, when treated with MPP+ and the combination of Poly (I:C) and MPP+.  However, MTT assay can only tell us that cell death occurred, and can’t specify what type of cell death.  MPP+ could be causing other forms of cell death apart form apoptosis, this is why the western blot doesn’t correlate with the MTT assay, as cCaspase- 3 can only indicate apoptosis.
  • 21. Conclusion  The neurotoxin MPP+ mimicking PD, significantly decreases cell viability, however we do not know by what means.  Poly I:C, the viral mimetic causes an increase cPARP expression indicating cCaspase-3 activity, indicting apoptosis may be occurring.
  • 22. Further Studies  Further studies should be carried out to determine what types of cell death occurs. Perhaps doing more western blots probing for proteins involved in other forms of cell death, such as necrosis or pyroptosis.  Different time points should be carried out as the dose of Poly I:C used is quiet small and doesn’t cause cell death immediately, it usually causes inflammation first.  Future experiments, should increase the n number, to get a better picture of the effects of both drugs in combination.
  • 23. Acknowledgements  I would like to thank Dr. Declan McKernan and Ms Laura Olsen.  I would also like to thank all the staff in the department of Pharmacology, especially the staff in the CNS lab.  Finally I would like to thank the girls in my group for all their help and support.